Literature DB >> 27540115

Binding of EBP50 to Nox organizing subunit p47phox is pivotal to cellular reactive species generation and altered vascular phenotype.

Imad Al Ghouleh1, Daniel N Meijles2, Stephanie Mutchler2, Qiangmin Zhang3, Sanghamitra Sahoo2, Anastasia Gorelova2, Jefferson Henrich Amaral2, Andrés I Rodríguez4, Tatyana Mamonova3, Gyun Jee Song5, Alessandro Bisello3, Peter A Friedman6, M Eugenia Cifuentes-Pagano2, Patrick J Pagano7.   

Abstract

Despite numerous reports implicating NADPH oxidases (Nox) in the pathogenesis of many diseases, precise regulation of this family of professional reactive oxygen species (ROS) producers remains unclear. A unique member of this family, Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox), respectively, the latter of which is functional in vascular smooth muscle cells (VSMC). In this manuscript, we identify critical requirement of ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50; aka NHERF1) for Nox1 activation and downstream responses. Superoxide (O2 (•-)) production induced by angiotensin II (AngII) was absent in mouse EBP50 KO VSMC vs. WT. Moreover, ex vivo incubation of aortas with AngII showed a significant increase in O2 (•-) in WT but not EBP50 or Nox1 nulls. Similarly, lipopolysaccharide (LPS)-induced oxidative stress was attenuated in femoral arteries from EBP50 KO vs. WT. In silico analyses confirmed by confocal microscopy, immunoprecipitation, proximity ligation assay, FRET, and gain-/loss-of-function mutagenesis revealed binding of EBP50, via its PDZ domains, to a specific motif in p47(phox) Functional studies revealed AngII-induced hypertrophy was absent in EBP50 KOs, and in VSMC overexpressing EBP50, Nox1 gene silencing abolished VSMC hypertrophy. Finally, ex vivo measurement of lumen diameter in mouse resistance arteries exhibited attenuated AngII-induced vasoconstriction in EBP50 KO vs. WT. Taken together, our data identify EBP50 as a previously unidentified regulator of Nox1 and support that it promotes Nox1 activity by binding p47(phox) This interaction is pivotal for agonist-induced smooth muscle ROS, hypertrophy, and vasoconstriction and has implications for ROS-mediated physiological and pathophysiological processes.

Entities:  

Keywords:  EBP50; NADPH oxidase; hypertrophy; smooth muscle; vascular tone

Mesh:

Substances:

Year:  2016        PMID: 27540115      PMCID: PMC5018796          DOI: 10.1073/pnas.1514161113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  61 in total

Review 1.  The Nox family of NADPH oxidases: friend or foe of the vascular system?

Authors:  Ina Takac; Katrin Schröder; Ralf P Brandes
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

2.  p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II.

Authors:  R M Touyz; G Yao; M T Quinn; P J Pagano; E L Schiffrin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-23       Impact factor: 8.311

Review 3.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

4.  NHERF1/EBP50 is a new marker in colorectal cancer.

Authors:  Yuho Hayashi; Jennifer R Molina; Stanley R Hamilton; Maria-Magdalena Georgescu
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

5.  Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways.

Authors:  B Lassègue; D Sorescu; K Szöcs; Q Yin; M Akers; Y Zhang; S L Grant; J D Lambeth; K K Griendling
Journal:  Circ Res       Date:  2001-05-11       Impact factor: 17.367

6.  NOX and inflammation in the vascular adventitia.

Authors:  Gábor Csányi; W Robert Taylor; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

7.  Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production.

Authors:  Sergey I Dikalov; Anna E Dikalova; Alfiya T Bikineyeva; Harald H H W Schmidt; David G Harrison; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

8.  Endogenous parathyroid hormone-related protein regulates the expression of PTH type 1 receptor and proliferation of vascular smooth muscle cells.

Authors:  Gyun Jee Song; Nathalie Fiaschi-Taesch; Alessandro Bisello
Journal:  Mol Endocrinol       Date:  2009-07-02

9.  Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1.

Authors:  Gábor Csányi; Mingyi Yao; Andrés I Rodríguez; Imad Al Ghouleh; Maryam Sharifi-Sanjani; Giovanna Frazziano; Xiaojun Huang; Eric E Kelley; Jeffrey S Isenberg; Patrick J Pagano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-18       Impact factor: 8.311

Review 10.  ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis.

Authors:  Benoît D'Autréaux; Michel B Toledano
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

View more
  12 in total

Review 1.  New roles of the Na+/H+ exchange regulatory factor 1 scaffolding protein: a review.

Authors:  Adrienne M Bushau-Sprinkle; Eleanor D Lederer
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

2.  Loss of the Na+/H+ Exchange Regulatory Factor 1 Increases Susceptibility to Cisplatin-Induced Acute Kidney Injury.

Authors:  Adrienne Bushau-Sprinkle; Michelle Barati; Caryl Conklin; Tess Dupre; Kenneth B Gagnon; Syed J Khundmiri; Barbara Clark; Leah Siskind; Mark A Doll; Madhavi Rane; Michael Brier; Susan Coventry; Eleanor D Lederer
Journal:  Am J Pathol       Date:  2019-03-27       Impact factor: 4.307

3.  Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.

Authors:  Enrico M Novelli; Lynda Little-Ihrig; Heather E Knupp; Natasha M Rogers; Mingyi Yao; Jeffrey J Baust; Daniel Meijles; Claudette M St Croix; Mark A Ross; Patrick J Pagano; Evan R DeVallance; George Miles; Karin P Potoka; Jeffrey S Isenberg; Mark T Gladwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

4.  Endothelial Nox1 oxidase assembly in human pulmonary arterial hypertension; driver of Gremlin1-mediated proliferation.

Authors:  Imad Al Ghouleh; Sanghamitra Sahoo; Daniel N Meijles; Jefferson H Amaral; Daniel S de Jesus; John Sembrat; Mauricio Rojas; Dmitry A Goncharov; Elena A Goncharova; Patrick J Pagano
Journal:  Clin Sci (Lond)       Date:  2017-07-16       Impact factor: 6.124

Review 5.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

6.  Bioluminescence-Based Complementation Assay to Correlate Conformational Changes in Membrane-Bound Complexes with Enzymatic Function.

Authors:  Sharon O'Neill; Ulla G Knaus
Journal:  Methods Mol Biol       Date:  2022

7.  NADPH oxidase 2 inhibitors CPP11G and CPP11H attenuate endothelial cell inflammation & vessel dysfunction and restore mouse hind-limb flow.

Authors:  Y Li; E Cifuentes-Pagano; E R DeVallance; D S de Jesus; S Sahoo; D N Meijles; D Koes; C J Camacho; M Ross; C St Croix; P J Pagano
Journal:  Redox Biol       Date:  2019-02-15       Impact factor: 11.799

8.  Nox1/Ref-1-mediated activation of CREB promotes Gremlin1-driven endothelial cell proliferation and migration.

Authors:  Daniel S de Jesus; Evan DeVallance; Yao Li; Micol Falabella; Danielle Guimaraes; Sruti Shiva; Brett A Kaufman; Mark T Gladwin; Patrick J Pagano
Journal:  Redox Biol       Date:  2019-02-08       Impact factor: 11.799

Review 9.  Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases.

Authors:  Luis H Gutiérrez-González; Selma Rivas-Fuentes; Silvia Guzmán-Beltrán; Angélica Flores-Flores; Jorge Rosas-García; Teresa Santos-Mendoza
Journal:  Molecules       Date:  2021-10-21       Impact factor: 4.411

10.  NHERF1 Loss Upregulates Enzymes of the Pentose Phosphate Pathway in Kidney Cortex.

Authors:  Adrienne Bushau-Sprinkle; Michelle T Barati; Kenneth B Gagnon; Syed Jalal Khundmiri; Kathleen Kitterman; Bradford G Hill; Amanda Sherwood; Michael Merchant; Shesh N Rai; Sudhir Srivastava; Barbara Clark; Leah Siskind; Michael Brier; Jessica Hata; Eleanor Lederer
Journal:  Antioxidants (Basel)       Date:  2020-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.